Storage Conditions
-20°C/1 year
Applications
ELISA
IF
IHC
WB
Concentration
1 mg/ml
Recomended Dilution
Western Blot: 1/500 - 1/2000. Immunohistochemistry: 1/100 - 1/300. ELISA: 1/10000. Not yet tested in other applications.
Type Clonality
Polyclonal
Immunogen
The antiserum was produced against synthesized peptide derived from human DIL-2. AA range:301-350
Subcellular Location
Nucleus . Cytoplasm, cytoskeleton, spindle . Cytoplasm, cytoskeleton, spindle pole . During mitosis it is strictly associated with the spindle pole and with the mitotic spindle, whereas during S and G2, it is diffusely distributed throughout the nucleus.
Iso type
IgG
Tissue Source
Rabbit
Reactivity
Human
Mouse
Human Gen
22974
Observed Band
86kD
Other Name
C20orf1
C20orf2
DIL-2
DIL2
Differentially expressed in cancerous and non-cancerous lung cells 2
HCA519
Hepatocellular carcinoma-associated antigen 519
Protein fls353
Restricted expression prolifera
TPX2
Targeting protein for Xklp2
Background
developmental stage:Exclusively expressed in proliferating cells from the transition G1/S until the end of cytokinesis.,PTM:Phosphorylated upon DNA damage, probably by ATM or ATR.,subcellular location:During mitosis it is strictly associated with the spin